Physician profile
Joseph Woolley
NPI 1790162063
$16,405.42
in general payments reported to CMS, 2019-2025
16 companies · $9,588 in 2025
The $9,588 reported for 2025 was more than what 93% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $287 · 2021: $637 · 2022: $174 · 2023: $1,437 · 2024: $4,096 · 2025: $9,588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $13K · Food and Beverage: $1,877 · Travel and Lodging: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $12,937.50 |
| Food and Beverage | $1,877.40 |
| Travel and Lodging | $305.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcresta Therapeutics, INC. | $13,835.58 | 2023-2025 | Relizorb |
| Genzyme Corporation | $558.52 | 2022-2025 | |
| Wilson Cook Medical Incorporated | $404.48 | 2021 | |
| Abbvie INC. | $362.44 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $236.37 | 2023 | Gattex |
| Ipsen Biopharmaceuticals, INC | $173.28 | 2024 | Bylvay |
| Janssen Biotech, INC. | $144.25 | 2019-2022 | |
| Mirum Pharmaceuticals, INC. | $143.45 | 2023 | Livmarli |
| Cook Medical LLC | $124.87 | 2021 | |
| Qol Medical, LLC | $115.89 | 2019-2021 | |
| Medtronic, INC. | $107.60 | 2023-2024 | Digitrapper, Endoflip |
| Janssen Scientific Affairs, LLC | $84.87 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $39.57 | 2024 | Dupixent |
| Chiesi USA, INC. | $29.29 | 2022 | |
| Allergan, INC. | $24.25 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orphalan INC | $20.71 | 2023 | Cuvrior |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Woolley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.